Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lostam BioPharmaceuticals

Out of Business LATEST DEAL TYPE

Developer of protein therapeutics designed to prevent and treat lethal Gram-negative bacterial infections. The company's protein therapeutics offers a panel of human therapeutic protein candidates and novel pipelines of anti-bacterial drugs capable of combating serious bacterial infections and of withstanding the cunning efforts of bacteria to develop drug-resistant mechanisms, enabling doctors to treat and prevent lethal Gram-negative bacterial infections associated primarily within the hospital setting.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Nazareth Industrial Area
  • PO Box 2252
  • Nazareth 16000
  • Israel
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lostam BioPharmaceuticals’s full profile, request a free trial.

Lostam BioPharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jul-2017 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Lostam BioPharmaceuticals Executive Team (1)

Name Title Board
Lewis Neville Ph.D Founder, Chief Technology Officer & Chief Executive Officer